Literature DB >> 32453686

Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China.

Weiwei Zhang, Weibin Cheng, Lei Luo, Yu Ma, Conghui Xu, Pengzhe Qin, Zhoubin Zhang.   

Abstract

We explored the secondary attack rate in different types of contact with persons presymptomatic for coronavirus disease (COVID-19). Close contacts who lived with or had frequent contact with an index case-patient had a higher risk for COVID-19. Our findings provide population-based evidence for transmission from persons with presymptomatic COVID-19 infections.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; China; SARS; SARS-CoV-2; coronavirus disease; coronavirus secondary transmission; presymptomatic; respiratory infections; secondary attack rate; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32453686      PMCID: PMC7392433          DOI: 10.3201/eid2608.201142

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading across the globe. Some case reports and modeling studies suggest asymptomatic carriage of SARS-CoV-2 plays a role in transmission (–). Studies have shown that 30%–59% of SARS-CoV-2 infections are asymptomatic (,), which poses tremendous infection control challenges. To control asymptomatic infections, China implemented active case surveillance and enhanced social distancing measures, which include contact tracing, quarantine for key populations, medical observation, and curtailed social activities (). However, additional information on the characteristics of presymptomatic transmission is needed to develop targeted control and prevention guidance. We analyzed contact-tracing surveillance data collected during January 28–March 15, 2020, to explore the secondary attack rate from different types of contact with persons presymptomatic for COVID-19 in Guangzhou, China. Asymptomatic COVID-19 cases were found mainly through close contact screening, clustered epidemic investigations, follow-up investigation of infection sources, and active surveillance of key populations with travel or residence history in areas with continuous transmission of COVID-19 in China and abroad. We developed a case definition for presymptomatic COVID-19, criteria for close contact, and contact investigation and management guidelines (Appendix). We estimated secondary attack rate (SAR) and 95% CI based on the proportion of COVID-19 incidence among close contacts. We calculated the mean reproductive number (R0) from the number of secondary infections observed among close contacts of each index case. The study was approved by the ethics committee of Guangzhou Center for Disease Control and Prevention, which granted a waiver for informed consent. Data collection was conducted under the authority of the China Center for Disease Control and Prevention. As of March 15, a total of 359 COVID-19 cases were confirmed in Guangzhou. Among them, 83 (23%) persons were asymptomatic at diagnosis; 71 (86%) of whom later developed symptoms. Among presymptomatic cases, 38 had >1 (range 1–90, median 4) close contact. We identified and included 369 close contacts in this study. Median age of close contacts was 35 years (range 0–93 years), 23.8% were family members of an index case, and 12 were confirmed to be infected via nucleic acid testing. Among them, 8 close contacts developed symptoms, and 4 were asymptomatic at the time of this study (Appendix Table). The overall SAR was 3.3% (95% CI 1.9%–5.6%). The SAR among household contacts was 16.1% and was 1.1% for social contacts, and 0 for workplace contacts. Older close contacts had the highest SAR compared with other age groups; 8.0% in persons >60 years of age compared with 1.4%–5.6% in persons <60 years of age. Close contacts of asymptomatic index case-patients had the lowest SAR, 0.8%, but the SAR was 3.5% for those with mild symptoms, 5.7% for those with moderate symptoms, and 4.5% for those with severe symptoms. Close contacts that lived with an index case-patient had 12 times the risk for infection and those who had frequent contact with an index case-patient, >5 contacts during 2 days before the index case was confirmed, had 29 times the risk for infection (Table).
Table

Characteristics of and secondary attack rates among 369 close contacts of persons with presymptomatic coronavirus disease 2019, China*

Variable
No. contacts
No. infected
Attack rate, % (95% CI)
Relative risk (95% CI)
Sex
M21752.3 (0.1–5.2)Referent
F
152
7
4.6 (2.2–8.9)
2.1 (0.6–6.6)
Age
≤174624.3 (1.2–14.5)Referent
18–3010432.9 (1.0–8.1)0.7 (0.1–4.1)
31–407211.4 (0.2–7.4)0.4 (0.03–3.5)
41–506811.5 (0.3–7.9)0.4 (0.03–3.7)
51–605435.6 (1.9–15.1)1.3 (0.2–8.1)
≥61
25
2
8.0 (1.4–27.5)
1.9 (0.3–14.5)
Index case-patient status*
Asymptomatic11910.8 (0.2–5.6)Referent
Mild symptoms14153.5 (1.5–8.0)4.3 (0.5–37.7)
Moderate symptoms8755.7 (2.5–12.8)7.2 (0.8–62.7)
Severe symptoms
22
1
4.5 (0.8–21.8)
5.6 (0.3–93.4)
Contact mode
Social interaction with friends or relatives6611.5 (0.3–8.1)Referent
Lived together621016.1 (9.0–27.2)12.5 (1.6–100.8)
Worked together119000
Social interaction with strangers
122
1
0.8 (0.2–4.9)
0.5 (0.03–8.7)
Contact frequency†
Rare14910.7 (0.1–3.7)Referent
Moderate15910.6 (0.1–3.5)0.9 (0.1–15.1)
Frequent
61
10
16.4 (9.2–27.6)
29.0 (3.6–232.3)
*Status as of March 30, 2020, based on the person’s clinical course assessed by a physician. Moderate symptoms included fever, respiratory symptoms, and radiographic evidence of pneumonia. Severe symptoms included breathing rate >30/min; oxygen saturation level <93% at rest; oxygen concentration level PaO2/FiO2 <300 mmHg (1 mmHg = 0.133kPa); lung infiltrates >50% within the past 24–48 h; respiratory failure requiring mechanical ventilation; septic shock; or multiple organ dysfunction or failure. All other symptomatic cases were classified as mild. 
†Rare contact was defined as contacted with index cases <2 times during 2 days preceding confirmation of infection. Moderate contact was defined as contacted with index cases 3–5 times during 2 days preceding confirmation of infection. Frequent contact was defined as contacted with index cases >5 times during 2 days preceding confirmation of infection.
Our findings substantiate previous reports from China and Germany (,,) and show that SARS-CoV-2 can be transmitted during asymptomatic COVID-19 infection period. The probability of infection increased substantially among close contacts who shared living environments or had frequent contact with an index case-patient, which underlines the need for prompt contact-based surveillance and social distancing (). Our results also showed most secondary infections occurred in confined familial clusters and that persons >60 years of age appear to be more vulnerable to being infected. These results are consistent with previous reports on epidemiologic characteristics of 72,314 COVID-19 cases in China () and suggest that household-based isolation should be cautiously implemented for persons with asymptomatic suspected cases. We also noted that persons with asymptomatic infections appeared to be less effective in transmitting the virus. However, this finding should not discourage isolation and surveillance efforts. The R0 in this cohort was 0.3 (95% CI 0.2–0.5), which was far smaller than the overall R0 of 2.2 reported previously (). This low transmission level could be the result of active surveillance, centralized quarantine, and forceful social-distancing strategies in Guangzhou. Interpretation of the findings should be taken with caution, and several limitations influence our estimation of the SAR. First, the number of close contacts was limited because we only included those who had been reached, and asymptomatic infections might have been missed. Second, we excluded close contacts who were exposed to >2 confirmed COVID-19 case-patients. Third, the presymptomatic transmission period is not well defined. Despite these limitations, our analysis provides valuable information on secondary transmission of SARS-CoV-2 in different types of contact with presymptomatic COVID-19 case-patients. Further evidence is needed to define the population characteristics, communicable period, and the volume and duration of viral shedding from persons with asymptomatic infections.

Appendix

Additional information on secondary transmission of coronavirus disease from presymptomatic persons, China
  8 in total

1.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

2.  Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.

Authors:  An Pan; Li Liu; Chaolong Wang; Huan Guo; Xingjie Hao; Qi Wang; Jiao Huang; Na He; Hongjie Yu; Xihong Lin; Sheng Wei; Tangchun Wu
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

3.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

Authors:  Camilla Rothe; Mirjam Schunk; Peter Sothmann; Gisela Bretzel; Guenter Froeschl; Claudia Wallrauch; Thorbjörn Zimmer; Verena Thiel; Christian Janke; Wolfgang Guggemos; Michael Seilmaier; Christian Drosten; Patrick Vollmar; Katrin Zwirglmaier; Sabine Zange; Roman Wölfel; Michael Hoelscher
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

5.  What to do next to control the 2019-nCoV epidemic?

Authors:  Fu-Sheng Wang; Chao Zhang
Journal:  Lancet       Date:  2020-02-08       Impact factor: 79.321

6.  Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020.

Authors:  Zhen-Dong Tong; An Tang; Ke-Feng Li; Peng Li; Hong-Ling Wang; Jing-Ping Yi; Yong-Li Zhang; Jian-Bo Yan
Journal:  Emerg Infect Dis       Date:  2020-05-17       Impact factor: 6.883

7.  Serial interval of novel coronavirus (COVID-19) infections.

Authors:  Hiroshi Nishiura; Natalie M Linton; Andrei R Akhmetzhanov
Journal:  Int J Infect Dis       Date:  2020-03-04       Impact factor: 3.623

  8 in total
  30 in total

Review 1.  Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans.

Authors:  Michael E Watson; Kengo Inagaki; Jason B Weinberg
Journal:  Comp Med       Date:  2021-09-17       Impact factor: 0.982

2.  Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries.

Authors:  Janneke D M Verberk; Marieke L A de Hoog; Ilse Westerhof; Sam van Goethem; Christine Lammens; Greet Ieven; Erwin de Bruin; Dirk Eggink; Julia A Bielicki; Samuel Coenen; Janko van Beek; Marc J M Bonten; Herman Goossens; Patricia C J L Bruijning-Verhagen
Journal:  Eur J Epidemiol       Date:  2022-05-28       Impact factor: 12.434

Review 3.  Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic.

Authors:  Yutong Wang; Ke Zheng; Wenjing Gao; Jun Lv; Canqing Yu; Lan Wang; Zijun Wang; Bo Wang; Chunxiao Liao; Liming Li
Journal:  Med Rev (Berl)       Date:  2022-02-24

4.  Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection.

Authors:  Swetha G Pinninti; Sunil Pati; Claudette Poole; Misty Latting; Maria C Seleme; April Yarbrough; Nitin Arora; William J Britt; Suresh Boppana
Journal:  Pediatrics       Date:  2021-02-23       Impact factor: 7.124

5.  Asymptomatic Cases, the Hidden Challenge in Predicting COVID-19 Caseload Increases.

Authors:  Brett Snider; Bhumi Patel; Edward McBean
Journal:  Infect Dis Rep       Date:  2021-04-09

6.  Major cardiac concerns in therapy and vaccinations for COVID-19.

Authors:  Syam Sundar Junapudi; Sunil Junapudi; Kishore Ega; Bojjibabu Chidipi
Journal:  Metabol Open       Date:  2021-06-29

7.  In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.

Authors:  Ruian Ke; Carolin Zitzmann; David D Ho; Ruy M Ribeiro; Alan S Perelson
Journal:  medRxiv       Date:  2021-06-30

8.  Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  medRxiv       Date:  2020-07-31

Review 9.  The Household Secondary Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Rapid Review.

Authors:  Hannah F Fung; Leonardo Martinez; Fernando Alarid-Escudero; Joshua A Salomon; David M Studdert; Jason R Andrews; Jeremy D Goldhaber-Fiebert
Journal:  Clin Infect Dis       Date:  2021-07-30       Impact factor: 20.999

Review 10.  Environmental and decontamination issues for human coronaviruses and their potential surrogates.

Authors:  Nevio Cimolai
Journal:  J Med Virol       Date:  2020-07-02       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.